References
- Benoit F. L., Thiel G. B., Watten R. H. Hydroxyprolinc excretion in the endocrinc disease. Metabolism 1963; 12: 1072
- Bessey O. A., Lowry O. H., Brock M. J. A method for the rapid determination of alkaline phos-phatase with five cubic niillimeters of sei-mi. J Biol Chem 1964; 164: 321
- Bodonna G., Merlino M. J., Laird Myers W. P., Sonenberg M. Urinary hydioxyproline and calcium metabolism in patients with cancer. New Engl J Med 1966; 275: 298
- Dull T. A., Henneman P. H. Urinary hydroxyprolinc as an index of collagen turnover in bone. New Engl J Med 1963; 268: 132
- Hosley H. F., Taft E. G., Olson K. B., Gates S., Beebe R. T. Hydroxyproline excretion in malignant neoplastic disease. Arch Intern Med 1966; 118: 565
- Jasin H. E., Fink C. V., Wise W., Ziff M. Relationship between urinary hydroxyproline and growth. J Clin Invest 1962; 41: 1928
- Ksts F. H., Kappas A. Influence of estradiol and estriol on urinary excretion of hydroxyproline in man. J Lab Clin Med 1968; 71: 65
- Kivirikko K., Laitinen O., Prockop D. J. Modifications of a specific assay for hydroxyproline In urine. Anal Biochem 1967; 19: 249
- Kivirikko K. J., Liesmaa M., Luukkainen T. Effect of growth hornlone and of pregnancy on the hydroxyproline concentration of the hlood of rats. Acta Endocrinol (Kbh) 1958; 27: 118
- Klein L., Lafferty F. W., Pearson O. H., Curtis P. H. Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnovei. Metabolism 1964; 13: 272
- Kletschke H. G. Ergebnisse der Hormonbehandlung des Prostatakarzinoms. Z Urol 1959; 52: 615
- Kontturi M., Kiviniitty K. Radiostrontium in the early diagnosis of bone rnetastase in patients with prostatic carcinoma. Scand J Urol Nephrol 1971; 5: 210
- Laitinen O., Nikkilä E. A., Kivirikko K. I. Hydroxyproline in the serum and urine. Normal values and clinical significance. Acta Med Scand 1966; 179: 275
- Mirejovska E., Beska F., Pitronova M. The significance of hydroxyprolinula for the proof of bone metastases of tumours. Neoplasms 1968; 77: 45
- Nakagawa M., Sugiura Y. Urinary hydroxy-proline in orthopedic disease with special reference to systemic bone disease and bone tumor. Nagoya J Med Sci 1967; 29: 345
- Parsons V., Baum M., Self M. Effect of mitra-mycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J 1967; 1: 474
- Rivto M. Bone and joint x-ray diagnosis2nd ed. Lea & Febiger, Philadelphia 1955
- Skosey J. L., Kappas A. Effect of estradiol on skin collagen turnover rate. Fed Proc 1967; 26: 426
- Stein W. H., Miller E. G., Jr. Composition of elastin. J Biol Chem 1938; 125: 1938
- Williams D. R., Bland W. H. The diagnostic and prognostic value of strontium-85 photoscanning in carcinoma of the prostate. J Urol 1967; 97: 1070